Table 1.
Subgroup | BMI | HR | 95% CI | I2 | Q-Test | Wald Test |
---|---|---|---|---|---|---|
General population | 15 | 1.60 | 1.39–1.84 | 86.1% | p < 0.001 | p < 0.001 |
20 | 1.13 | 1.07–1.18 | ||||
25 | 1.00 | 1.00–1.00 | ||||
30 | 1.12 | 1.06–1.18 | ||||
35 | 1.58 | 1.35–1.84 | ||||
40 | 2.80 | 2.05–3.82 | ||||
Elderly | 15 | 2.68 | 1.40–5.11 | 81.7% | p < 0.001 | p < 0.001 |
20 | 1.36 | 1.10–1.68 | ||||
25 | 1.00 | 1.00–1.00 | ||||
30 | 1.07 | 1.00–1.15 | ||||
35 | 1.68 | 1.23–2.29 | ||||
40 | 3.84 | 1.74–8.44 | ||||
Diabetes | 15 | 2.14 | 1.73–2.65 | 84.3% | p < 0.001 | p < 0.001 |
20 | 1.31 | 1.22–1.40 | ||||
25 | 1.00 | 1.00–1.00 | ||||
30 | 0.96 | 0.94–0.98 | ||||
35 | 1.15 | 1.07–1.24 | ||||
40 | 1.74 | 1.41–2.14 | ||||
CVD | 15 | 2.45 | 1.95–3.09 | 91.5% | p < 0.001 | p < 0.001 |
20 | 1.42 | 1.29–1.57 | ||||
25 | 1.00 | 1.00–1.00 | ||||
30 | 0.85 | 0.79–0.92 | ||||
35 | 0.89 | 0.77–1.02 | ||||
40 | 1.11 | 0.88–1.40 | ||||
Cancer | 15 | 1.49 | 1.17–1.90 | 73.9% | p < 0.001 | p < 0.001 |
20 | 1.13 | 1.02–1.24 | ||||
25 | 1.00 | 1.00–1.00 | ||||
30 | 1.04 | 0.98–1.11 | ||||
35 | 1.27 | 1.12–1.44 | ||||
40 | 1.83 | 1.46–2.28 | ||||
Other | 15 | 2.00 | 1.55–2.58 | 82.3% | p < 0.001 | p < 0.001 |
20 | 1.31 | 1.19–1.45 | ||||
25 | 1.00 | 1.00–1.00 | ||||
30 | 0.88 | 0.83–0.94 | ||||
35 | 0.90 | 0.81–1.01 | ||||
40 | 1.07 | 0.89–1.29 |
BMI—body-mass index, CI—confidence interval, CVD—cardiovascular disease, HR—hazard ratio.